Down Syndrome Stem Cell Treatment in Delhi, India

Published on: June 16, 2020Updated on: November 6, 2025BY Viezec
down syndrome

Key Takeaways

  • 01. Use of mesenchymal stem cells:
    The procedure uses adult mesenchymal stem cells extracted from sources like the umbilical cord or bone marrow to support neurological and immune functions.
  • 02. Goal is functional improvement, not cure:
    The therapy aims to enhance motor skills, mental functions, and immunity rather than reverse the genetic cause of Down Syndrome.
  • 03. Treatment remains experimental with variable outcomes:
    Viezec notes that standardized large-scale clinical data is limited and outcomes may vary significantly between patients.
  • 04. Access and cost considerations in India:
    The service is available in Delhi NCR, focusing on international patient access. The article discusses cost factors, though specific pricing is not detailed.

Conclusion

Stem cell therapy for Down Syndrome offers promising potential to enhance cognitive, motor, and overall developmental functions by addressing the condition at a cellular level. At Viezec, we combine advanced regenerative medicine protocols with compassionate, patient-centered care to support individuals and families seeking holistic treatment solutions. Our team works with accredited hospitals and ethical medical practices to ensure safe, transparent, and effective procedures. As a trusted healthcare facilitator in India, Viezec continues to help patients access world-class therapy and personalized care plans. If you or your loved one is exploring stem cell treatment options for Down Syndrome, connect with our experts today to learn how regenerative medicine can improve quality of life.

Ask Your Query





    Our Testimonials

    Related Videos

    Recent Blog Posts

    Patients Rating

    4.8 average based on 654 reviews.


    5 star
    392
    4 star
    176
    3 star
    49
    2 star
    30
    1 star
    7

    Upload your reports today for a free online consultation

    Upload Reports






      Menu